Coloplast A/S - FY 2023/24 Earnings Release - Invitation For Conference Call On 5 November 2024 At 11.00 CET
Date
10/21/2024 6:16:29 AM
(MENAFN- GlobeNewsWire - Nasdaq) Tuesday, 5 November 2024 at 11.00 – 12.00 CET
In connection with the publication of Coloplast's interim financial results for FY 2023/24 the company will host a conference call to present the financial results and answer questions from investors and financial analysts.
A presentation will be available on Coloplast's website approximately 1 hour before the conference call.
Please note that the webcast of the conference call will be available during and after the event.
Coloplast will be represented by:
Kristian Villumsen - President & CEO
Anders Lonning-Skovgaard - Executive Vice President, CFO
Aleksandra Dimovska - Vice President, Investor Relations
Kristine Husted Munk - Senior Manager, Investor Relations
Webcast
Any participants who do not wish to actively participate in the question & answer session, please access the conference call as a webcast directly by clicking here:
Access the webcast here
Dial-in details
For analysts and any participants wishing to actively participate in the question & answer session please sign up ahead of the conference call on the link below to receive an email with dial-in details:
Register here
For more information, please contact:
Aleksandra Dimovska, Vice President, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 2458, e-mail: ...
Kristine Husted Munk, Senior Manager, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 3266, e-mail: ...
Julie Sommer Müggler, Coordinator & PA, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 3161, e-mail: ...
Konstancija Norvilaite, Associate IR & Finance Manager, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 2803, e-mail: ...
Coloplast will be available on individual phone lines after the conference call for further questions.
Attachment
Invitation for Coloplasts FY 2023-24 conference call on 5 November 2024
MENAFN21102024004107003653ID1108802070
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.